Nexus AG: Very strong sales and earnings increase in the third quarter 2025

Donaueschingen (pta007/04.11.2025/08:45 UTC+1)

Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its sales by approx. 10% and EBIT by approx. 16% in the first nine months of 2025. As a result, the continually positive development of sales and earnings of the last years could be continued.

Sales improved from KEUR 190,805 to KEUR 209,671 (+9.9%) in the first nine months 2025. The international share of total business volume was 39.6% (9M-2024: 43.7%) and amounted to KEUR 83,048 compared to KEUR 83,382 (9M-2024).

The EBITA rose very sharply by 15.9% from KEUR 31,743 (9M-2024) to KEUR 36,798. Consolidated earnings before interest and taxes (EBIT) rosed sharp by 15.8% to KEUR 31,484 (9M-2024: KEUR 27,179). The consolidated surplus increased by 14.0% to KEUR 23,094 (9M-2024: KEUR 20,267) and EBITDA increased by 12.4% to KEUR 45,928 (9M-2024 KEUR 40,856).

As of 30/09/2025, the company had cash resources at its disposal in the amount of KEUR 126,674 (31/12/2024: KEUR 114,038). Nexus AG had equity capital amounting to KEUR 304,858 as of 30/09/2025 (31/12/2024: KEUR 282,958). Consequently, the equity capital rate is 62.3 % (31/12/2024: 64.6 %).

Donaueschingen, November 4th 2025

The Managing Board

(end)

Emitter:	Nexus AG Irmastraße 1 78166 Donaueschingen Germany
Contact Person:	Hannes Wehinger
Phone:	+49 771 22960-260
E-Mail:	ir@nexus-ag.de
Website:	www.nexus-ag.de
ISIN(s):	DE0005220909 (Share)
Stock Exchange(s):	Regulated Market in Frankfurt; Free Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate